Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV000788345 | SCV000927417 | uncertain significance | not provided | 2017-10-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001238825 | SCV001411654 | uncertain significance | Lymphoproliferative syndrome 2 | 2023-08-08 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CD27 protein function. ClinVar contains an entry for this variant (Variation ID: 636496). This variant has not been reported in the literature in individuals affected with CD27-related conditions. This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 124 of the CD27 protein (p.Pro124Arg). This variant is present in population databases (rs373809759, gnomAD 0.02%). |
Ce |
RCV000788345 | SCV002497195 | uncertain significance | not provided | 2022-02-01 | criteria provided, single submitter | clinical testing |